Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Duval

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Histopathology|March 8, 2012
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathwayHervé Sartelet, Tina Imbriglio, Carine Nyalendo, et al.
Blood|April 4, 2002
Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trialMichel Duval, Stefan Suciu, Alina Ferster, et al.
Therapeutic Drug Monitoring|September 25, 2013
Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantationMarc Ansari, Yves Théoret, Mohamed Aziz Rezgui, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|July 15, 2026
Pediatric Oncology Knowledge Mobilization in Canada: A Environmental ScanCatherine Foulem, Emily K Drake, Angelina Lui, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell TransplantationTiago Nava, Mohamed A Rezgui, Chakradhara R S Uppugunduri, et al.
Transfusion|September 21, 2007
Complications of apheresis in childrenBruno Michon, Albert Moghrabi, Rochelle Winikoff, et al.
Sage Open Pediatrics|November 3, 2025
Knowledge Mobilization Efforts by Global Pediatric Oncology Civil Society Organizations: An Environmental Scan ProtocolEmily K Drake, Angelina Lui, Ekaterini Damoulianos, et al.
Journal for Immunotherapy of Cancer|May 16, 2024
Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settingsNicolas Poirier, Valérie Paquin, Séverine Leclerc, et al.
Bone Marrow Transplantation|September 3, 2021
Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in childrenThomas Pincez, Raoul Santiago, Henrique Bittencourt, et al.
Journal of Pediatric Hematology/Oncology|February 11, 2005
Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocolsJean-Hugues Dalle, Albert Moghrabi, Pierre Rousseau, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Histopathology|March 8, 2012
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathwayHervé Sartelet, Tina Imbriglio, Carine Nyalendo, et al.
Blood|April 4, 2002
Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trialMichel Duval, Stefan Suciu, Alina Ferster, et al.
Therapeutic Drug Monitoring|September 25, 2013
Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantationMarc Ansari, Yves Théoret, Mohamed Aziz Rezgui, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|July 15, 2026
Pediatric Oncology Knowledge Mobilization in Canada: A Environmental ScanCatherine Foulem, Emily K Drake, Angelina Lui, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2017
GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell TransplantationTiago Nava, Mohamed A Rezgui, Chakradhara R S Uppugunduri, et al.
Transfusion|September 21, 2007
Complications of apheresis in childrenBruno Michon, Albert Moghrabi, Rochelle Winikoff, et al.
Sage Open Pediatrics|November 3, 2025
Knowledge Mobilization Efforts by Global Pediatric Oncology Civil Society Organizations: An Environmental Scan ProtocolEmily K Drake, Angelina Lui, Ekaterini Damoulianos, et al.
Journal for Immunotherapy of Cancer|May 16, 2024
Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settingsNicolas Poirier, Valérie Paquin, Séverine Leclerc, et al.
Bone Marrow Transplantation|September 3, 2021
Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in childrenThomas Pincez, Raoul Santiago, Henrique Bittencourt, et al.
Journal of Pediatric Hematology/Oncology|February 11, 2005
Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocolsJean-Hugues Dalle, Albert Moghrabi, Pierre Rousseau, et al.
Pageof 11